Breaking News: Opportunity for Investors to Join Class Action Lawsuit Against Zynex, Inc.
Los Angeles, CA – March 31, 2025
The Law Offices of Frank R. Cruz announces that all investors who purchased or otherwise held Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) securities between January 1, 2021, and March 29, 2025, and incurred losses, are encouraged to contact the firm before the lead plaintiff deadline in a securities class action lawsuit against Zynex.
Background on Zynex, Inc.
Zynex is a medical technology company that designs, manufactures, and markets medical devices and software. The company’s products are used for the treatment of chronic pain, wound care, and neurodiagnostics. Zynex’s stock has experienced significant volatility in recent months, leading to concerns among investors.
Allegations of Securities Fraud
The class action lawsuit alleges that Zynex and certain of its executives made false and misleading statements regarding the Company’s business, operational, and financial metrics. Specifically, the complaint alleges that the defendants failed to disclose material information about the Company’s sales practices and financial condition, leading to artificially inflated stock prices.
Impact on Individual Investors
If you invested in Zynex securities during the specified time frame and incurred losses, you may be entitled to compensation. The lead plaintiff deadline is approaching, so it is important that you contact the Law Offices of Frank R. Cruz as soon as possible to discuss your potential recovery options.
Impact on the World
The securities fraud allegations against Zynex could have far-reaching implications for the medical technology industry and beyond. If the allegations are proven true, it could lead to increased scrutiny of other companies in the sector, as well as increased regulation and oversight. It could also lead to a loss of confidence in the market, which could negatively impact investor sentiment and stock prices.
Conclusion
The Law Offices of Frank R. Cruz is committed to helping investors recover their losses. If you invested in Zynex securities during the specified time frame and incurred losses, we encourage you to contact us as soon as possible to discuss your potential recovery options. We will continue to monitor developments in this case and provide updates as new information becomes available.
- Investors who purchased or otherwise held Zynex securities between January 1, 2021, and March 29, 2025, and incurred losses, are encouraged to contact the Law Offices of Frank R. Cruz before the lead plaintiff deadline.
- The class action lawsuit alleges that Zynex and certain executives made false and misleading statements regarding the Company’s business, operational, and financial metrics.
- The allegations of securities fraud could have far-reaching implications for the medical technology industry and beyond.
